Stock DNA
Capital Markets
USD 155,720 Million (Large Cap)
55.00
NA
40.60%
-999,999.00
53.16%
25.60
Total Returns (Price + Dividend) 
Ameriprise Financial, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
Is Ameriprise Financial, Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Ameriprise Financial, Inc. has moved from very attractive to attractive, indicating a shift towards a more cautious outlook. The company appears to be overvalued based on its current metrics, particularly with a P/E ratio of 55, a price to book value of 30.32, and an EV to EBITDA of 38.44. In comparison, State Street Corp. has a P/E of 16.53, and LPL Financial Holdings, Inc. has a P/E of 34.83, suggesting that Ameriprise is trading at a significant premium relative to its peers. Despite its strong ROE of 55.32%, the high valuation ratios raise concerns about sustainability and growth potential. Over the past year, Ameriprise has underperformed the S&P 500, with a return of -10.88% compared to the index's 19.89%, further reinforcing the notion that the stock may be overvalued in the current market environment....
Read MoreIs Ameriprise Financial, Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Ameriprise Financial, Inc. moved from very attractive to attractive. The company appears to be overvalued based on its current valuation metrics. The P/E ratio stands at 55, significantly higher than the peer average of 48.17, while the EV to EBITDA ratio is 38.44, which also exceeds the industry average. Additionally, the Price to Book Value is at 30.32, indicating a premium over its book value compared to peers like The Charles Schwab Corp., which has a P/E of 25.67 and an EV to EBITDA of 9.95. In terms of performance, Ameriprise has underperformed relative to the S&P 500 over the past year, with a return of -10.80% compared to the index's 19.89%. This trend is further emphasized by its year-to-date return of -15.03% against the S&P 500's 16.30%. Given these valuation ratios and the recent stock performance, Ameriprise Financial, Inc. seems to be trading at ...
Read MoreIs Ameriprise Financial, Inc. overvalued or undervalued?
As of 31 October 2025, the valuation grade for Ameriprise Financial, Inc. has moved from very attractive to attractive, indicating a shift in perceived value. The company appears to be overvalued based on its current metrics, with a P/E ratio of 55, a Price to Book Value of 30.32, and an EV to EBITDA of 38.44. In comparison, peers such as Morgan Stanley have a P/E of 18.52, while The Charles Schwab Corp. boasts a more favorable P/E of 25.67, highlighting the relative overvaluation of Ameriprise. Despite the attractive dividend yield of 37.68% and a strong ROE of 55.32%, the high valuation ratios suggest that the stock may not be justified at its current price of 452.77. Recent performance shows that Ameriprise has underperformed against the S&P 500, with a year-to-date return of -14.96% compared to the index's 16.30%, further reinforcing the notion of overvaluation in the current market context....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Mar 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 166 Schemes (35.08%)
Held by 401 Foreign Institutions (20.21%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - YoY
YoY Growth in quarter ended Jun 2025 is 2.07% vs 9.97% in Jun 2024
YoY Growth in quarter ended Jun 2025 is 27.86% vs -6.85% in Jun 2024
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 11.55% vs 12.47% in Dec 2023
YoY Growth in year ended Dec 2024 is 33.06% vs -18.83% in Dec 2023






